Organoids and Spheroids Market
Global Organoids And Spheroids Market was valued at USD 1.1 billion in 2023 growing at a CAGR of 19.1% between 2024 and 2032, due to advancements in biotechnology, particularly in 3D cell culture and bioengineering, coupled with the rising demand for personalized medicine. The influx of technologies is enabling precise disease modeling, drug testing, and tailored treatment approaches for enhancing therapeutic efficacy and patient outcomes.With increasing applications across pharmaceutical research and regenerative medicine, organoids and spheroids offer innovative solutions to cater to the complexities of diseases, driving growth in both research and clinical settings globally. For instance, in January 2024, HUB Organoids HUB introduced the IntegriGut Screen by utilizing IBD patient-derived organoid monolayers PDO monolayers to provide crucial human data on epithelial barrier function.The organoids and spheroids industry is classified into type, application, end-use, and region.By end-use, the academic and research institutes segment will experience robust growth through 2032, attributed to the pivotal role in advancing biotechnological research. These institutions are driving innovations in 3D cell culture technologies for enhancing disease modeling and drug testing capabilities. With robust funding and collaborations with pharmaceutical companies, academic and research institutes are contributing significantly to therapeutic development and personalized medicine.In terms of application, the organoids and spheroids market from the personalized medicine segment will witness substantial CAGR between 2024 and 2032, propelled by the tailored approach to treatment. Organoids and spheroids offer precise disease modeling and drug testing, which is crucial for developing patient-specific therapies. With advancements in biotechnology and increased adoption in pharmaceutical research, personalized medicine is also leveraging 3D cell culture models to optimize treatment outcomes, driving significant segment growth.Asia Pacific organoids and spheroids market will demonstrate a decent CAGR between 2024 and 2032, spurred by increasing investments in biotechnology and pharmaceutical sectors. The robust research infrastructure and growing healthcare expenditure is fostering the adoption of advanced 3D cell culture technologies. With rising initiatives in drug discovery and personalized medicine, Asia Pacific will stand out as a key contributor to the industry growth.
- Chapter 1 Methodology
- 1.1 Market segmentation
- 1.2 Market definitions
- 1.3 Research design
- 1.4 Market size estimates and calculations
- 1.4.1 Approach 1: Company share analysis
- 1.5 Forecast model
- 1.6 Key trends for market estimates
- 1.7 Primary research & validation
- 1.7.1 Primary sources
- 1.7.2 Data mining sources
- 1.7.2.1 Paid sources
- 1.7.2.2 Public sources
- Chapter 2 Executive Summary
- 2.1 Industry 360° synopsis, 2018 - 2032
- 2.2 Type trends
- 2.3 Application trends
- 2.4 End use trends
- 2.5 Regional trends
- Chapter 3 Organoids and Spheroids Market Industry Insights
- 3.1 Industry ecosystem analysis
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Advancement in cell culture technologies
- 3.2.1.2 Increase in demand for personalized medicine
- 3.2.1.3 Rise in prevalence of chronic disease
- 3.2.1.4 Technological advancement in 3D spheroid
- 3.2.2 Industry pitfalls & challenges
- 3.2.2.1 Lack of robust disease models
- 3.2.2.2 High cost of development and maintenance
- 3.3 Growth potential analysis
- 3.3.1 By type
- 3.3.3 By end use
- 3.4 Regulatory landscape
- 3.4.1 U.S.
- 3.4.2 Europe
- 3.5 Technology landscape
- 3.6 Porter's analysis
- 3.7 PESTEL analysis
- Chapter 4 Competitive Landscape, 2023
- 4.1 Introduction
- 4.1.1 Thermo Fisher Scientific Inc.
- 4.1.2 Corning Incorporated
- 4.1.3 InSphero
- 4.2 Company market share analysis
- 4.3 Company matrix analysis
- 4.4 Competitive analysis of major market players
- 4.5 Competitive positioning matrix
- 4.6 Strategic dashboard
- Chapter 5 Organoids and Spheroids Market, By Type
- 5.1 Organoids
- 5.1.1 Type
- 5.1.1.1 Neural organoids
- 5.1.1.2 Hepatic organoids
- 5.1.1.3 Intestinal organoids
- 5.1.1.4 Other organoids
- 5.1.2 Method
- 5.1.2.1 General submerged method for organoid culture
- 5.1.2.2 Crypt organoid culture techniques
- 5.1.2.3 Air liquid interface (ALI) method
- 5.1.2.4 Other organoid methods
- 5.1.3 Source
- 5.1.3.1 Primary tissue
- 5.1.3.2.1 Stem cells
- 5.2 Spheroids
- 5.2.1 Type
- 5.2.1.1 Multicellular tumor spheroids
- 5.2.1.2 Neurospheres
- 5.2.1.3 Mammospheres
- 5.2.1.4 Hepatospheres
- 5.2.2 Method
- 5.2.2.1 Micropatterned plates
- 5.2.2.2 Low cell attachment plates
- 5.2.2.3 Hanging drop method
- 5.2.2.4 Other spheroid methods
- 5.2.3 Source
- 5.2.3.1 Cell line
- 5.2.3.2 iPSCs derived cells
- Chapter 6 Organoids and Spheroids Market, By Application
- 6.1 Developmental biology
- 6.2 Drug discovery and personalized medicine
- 6.3 Regenerative medicine
- 6.4 Disease pathology studies
- 6.5 Drug toxicity & efficacy testing
- Chapter 7 Organoids and Spheroids Market, By End Use
- 7.1 Pharmaceuticals and biotechnology companies
- 7.2 Academic and research institutes
- 7.3 Hospitals and diagnostic centers
- Chapter 8 Organoids and Spheroids Market, By Region
- 8.1 North America
- 8.2 Europe
- 8.3 Asia Pacific
- 8.4 Latin America
- 8.5 Middle East and Africa Chapter 9 Company Profiles
- 9.1 AMSBIO
- 9.1.1 Global overview
- 9.1.2 Business overview
- 9.1.3 Financial data
- Organoids and Spheroids Market Report, 2032
- 9.1.4 Product landscape
- 9.1.5 SWOT analysis
- 9.2 Corning Incorporated
- 9.2.1 Global overview
- 9.2.2 Business overview
- 9.2.1 Financial data
- 9.2.1.1 Annual sales revenue, 2020-2023 (USD Million)
- 9.2.2 Product landscape
- 9.2.3 SWOT analysis
- 9.3 Greiner AG
- 9.3.1 Global overview
- 9.3.2 Business overview
- 9.3.3 Financial data
- 9.3.3.1 Annual sales revenue, 2020-2023 (USD Million)
- 9.3.4 Product landscape
- 9.3.5 SWOT analysis
- 9.4 InSphero
- 9.4.1 Global overview
- 9.4.2 Business overview
- 9.4.3 Financial data
- 9.4.4 Product landscape
- 9.4.5 Strategic outlook
- 9.4.6 SWOT analysis
- 9.5 Lonza Ltd
- 9.5.1 Global overview
- 9.5.2 Business overview
- 9.5.3 Financial data
- 9.5.3.1 Annual sales revenue, 2020-2023 (USD Million)
- 9.5.4 Product landscape
- 9.5.5 Strategic outlook
- 9.5.6 SWOT analysis
- 9.6 Merck KGaA
- 9.6.1 Global overview
- 9.6.2 Business overview
- 9.6.3 Financial data
- 9.6.3.1 Annual sales revenue, 2020-2023 (USD Million)
- 9.6.4 Product landscape
- 9.6.5 SWOT analysis
- 9.7 Prellis Biologics
- 9.7.1 Global overview
- 9.7.2 Business overview
- 9.7.3 Financial data
- 9.7.4 Product landscape
- 9.7.5 Strategic outlook
- 9.7.6 SWOT analysis
- 9.8 Promega Corporation
- 9.8.1 Global overview
- 9.8.2 Business overview
- 9.8.3 Financial data
- 9.8.4 Product landscape
- 9.8.5 SWOT analysis
- 9.9 STEMCELL Technologies
- 9.9.1 Global overview
- 9.9.2 Business overview
- 9.9.3 Financial data
- 9.9.4 Product landscape
- 9.9.5 Strategic outlook
- 9.9.6 SWOT analysis
- 9.10Thermo Fisher Scientific, Inc.
- 9.10.1 Global overview
- 9.11Business overview
- 9.12Financial data
- 9.12.1.1 Annual sales revenue, 2020 – 2023 (USD Million)
- 9.13Product landscape
- 9.14SWOT analysis
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook